Cevian Capital II GP LTD holds a concentrated book of 3 stocks worth $3.1B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). Their largest long position is UBS Group AG-Reg at 60% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1365341/holdings"
Use Arkolith to show Cevian Capital II GP LTD's latest holdings, largest changes, and filing provenance.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | UBS Group AG SHS | $1.9B | 48.12M | 60.3% | —Held | |
| 2 | Autoliv Inc COM | $662.4M | 6.30M | 21.2% | —Held | |
| 3 | CRH PLC ORD | $575.7M | 5.48M | 18.5% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 3 | $3.1B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 3 | $3.7B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 3 | $3.4B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 3 | $2.8B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 3 | $2.4B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 3 | $2.6B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 3 | $3.2B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 | 3 | $3.0B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 | 3 | $3.5B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 3 | $4.0B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 2 | $2.4B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 1 | $535.6M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 1 | $588.0M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 14, 2023 | 1 | $482.3M | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 1 | $419.7M | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 | 1 | $422.9M | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 | 2 | $748.1M | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 2 | $895.7M | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 15, 2021 | 2 | $779.8M | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 16, 2021 | 2 | $762.6M | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 17, 2021 | 2 | $744.8M | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 16, 2021 | 2 | $715.1M | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 16, 2020 | 2 | $548.6M | 13F-HR |
| Q2 2020 | Jun 30, 2020 | Aug 14, 2020 | 2 | $455.0M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.